CN1193979C - Jasmine keto ester derivatives and their use in plant cell - Google Patents
Jasmine keto ester derivatives and their use in plant cell Download PDFInfo
- Publication number
- CN1193979C CN1193979C CN 03129466 CN03129466A CN1193979C CN 1193979 C CN1193979 C CN 1193979C CN 03129466 CN03129466 CN 03129466 CN 03129466 A CN03129466 A CN 03129466A CN 1193979 C CN1193979 C CN 1193979C
- Authority
- CN
- China
- Prior art keywords
- day
- compound
- group
- och
- plant cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- -1 keto ester Chemical class 0.000 title claims abstract description 22
- 241000196324 Embryophyta Species 0.000 title abstract description 8
- 235000010254 Jasminum officinale Nutrition 0.000 title 1
- 240000005385 Jasminum sambac Species 0.000 title 1
- 229930194542 Keto Natural products 0.000 title 1
- 229930000044 secondary metabolite Natural products 0.000 claims abstract description 6
- 230000012010 growth Effects 0.000 claims abstract description 3
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N (-)-Jasmonic acid Natural products CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 claims description 45
- ZNJFBWYDHIGLCU-UHFFFAOYSA-N jasmonic acid Natural products CCC=CCC1C(CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-UHFFFAOYSA-N 0.000 claims description 26
- 150000001875 compounds Chemical class 0.000 claims description 22
- 235000013311 vegetables Nutrition 0.000 claims description 6
- 125000003816 2-hydroxybenzoyl group Chemical group OC1=C(C(=O)*)C=CC=C1 0.000 claims description 2
- 239000002243 precursor Substances 0.000 abstract description 4
- 241001116500 Taxus Species 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 229910052731 fluorine Inorganic materials 0.000 abstract description 3
- 239000011737 fluorine Substances 0.000 abstract description 3
- 239000005648 plant growth regulator Substances 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- XMLSXPIVAXONDL-PLNGDYQASA-N Jasmone Chemical compound CC\C=C/CC1=C(C)CCC1=O XMLSXPIVAXONDL-PLNGDYQASA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 230000001939 inductive effect Effects 0.000 abstract 2
- 150000004702 methyl esters Chemical class 0.000 abstract 2
- XMLSXPIVAXONDL-UHFFFAOYSA-N trans-jasmone Natural products CCC=CCC1=C(C)CCC1=O XMLSXPIVAXONDL-UHFFFAOYSA-N 0.000 abstract 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 240000005130 Tamarix chinensis Species 0.000 abstract 1
- 229940123237 Taxane Drugs 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 abstract 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 17
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 239000007788 liquid Substances 0.000 description 14
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 description 9
- 238000001914 filtration Methods 0.000 description 8
- 230000002194 synthesizing effect Effects 0.000 description 8
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- 229930012538 Paclitaxel Natural products 0.000 description 6
- 150000005690 diesters Chemical class 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 241001149649 Taxus wallichiana var. chinensis Species 0.000 description 5
- 229940125904 compound 1 Drugs 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229960001592 paclitaxel Drugs 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 5
- 150000001263 acyl chlorides Chemical class 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- CUBCNYWQJHBXIY-UHFFFAOYSA-N benzoic acid;2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1O CUBCNYWQJHBXIY-UHFFFAOYSA-N 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 229940125898 compound 5 Drugs 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Natural products OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 238000006471 dimerization reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- OVSKIKFHRZPJSS-DOMIDYPGSA-N 2-(2,4-dichlorophenoxy)acetic acid Chemical compound OC(=O)[14CH2]OC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-DOMIDYPGSA-N 0.000 description 1
- 239000005972 6-Benzyladenine Substances 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- KSMITTDZTTZFML-LURJTMIESA-N Jasminine Chemical compound C[C@@H]1NC(=O)CC2=C1C=NC=C2C(=O)OC KSMITTDZTTZFML-LURJTMIESA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- HSJPMRKMPBAUAU-UHFFFAOYSA-N cerium(3+);trinitrate Chemical compound [Ce+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O HSJPMRKMPBAUAU-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- AQYSYJUIMQTRMV-UHFFFAOYSA-N hypofluorous acid Chemical compound FO AQYSYJUIMQTRMV-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- KSMITTDZTTZFML-ZCFIWIBFSA-N jasminine Natural products O=C(OC)c1c2c([C@@H](C)NC(=O)C2)cnc1 KSMITTDZTTZFML-ZCFIWIBFSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- RMBAVIFYHOYIFM-UHFFFAOYSA-M sodium methanethiolate Chemical compound [Na+].[S-]C RMBAVIFYHOYIFM-UHFFFAOYSA-M 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000004579 taxol derivatives Chemical class 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention discloses a structure of a novel jasmone acid ester compound and an application thereof in the growth promotion of the secondary metabolite of a plant cell. A yew (T. chinensis) cell of the China is selected by the present invention as an application system, and a jasmone acid methyl ester (MJA) structure is used as a precursor, and a series of plant cell inductive agents are designed and synthesized by leading in precursors containing fluorine, hydroxy groups and some plant growth regulators. An experimental result indicates that the performance of partial inductive agents is superior to the performance of MJA in the aspect of the biosynthesis promotion of taxane, and have conference value.
Description
Technical field
The present invention relates to novel jasmonic acid ester compound of a class and uses thereof.
Background technology
The abundant plant resources of nature is containing a considerable number of secondary metabolite, comprising the pharmaceuticals of many costlinesses.In order to develop these valuable resources, maybe might carry out the chemosynthesis except extracting from material of vegetable origin, the external large scale culturing technology of vegetable cell also is an effective approach.Utilize inductor to carry out the concern that secondary metabolite regulation and control have obtained more and more Chinese scholars, and become one of important method that increases substantially secondary metabolite content in the culture (Xie Qiuling, Guo Yong, Food science, 1998,19 (10), 7-9).
Taxol is the secondary metabolite that contains in the class Chinese yew genus plants, owing to its unique anticancer mechanism and curative effect, is considered to cancer patients's choice drug at present.According to estimates, the sales volume of taxol in 2000 reaches 1,600,000,000 US dollars (A.M.Thayer.Chem.Eng.News., 2000,78 (45), 20).Therefore, the various countries scientific research personnel has carried out extensive studies to the output that how to improve taxol.Because Chinese yew poor growth and distribution are narrow, directly extraction can't be satisfied market demand and unfavorable to environment.Though it is complete synthesis finishes, productive rate is too low can't realize mass production ((1) R.A.Holton, C.Somoza, et al., J.Am.Chem.Soc., 1994,116,1957, (2) K.C.Nicolaou, Z.Yang, et al., Nature, 1994,367,630).At present, most taxols and taxol precursor compound all are to utilize various yew plant cells to cultivate acquisition under the inductor effect.
The inductor that utilizes yew plant cells to cultivate taxol generally divides two kinds, promptly biological and abiotic inductor.The biotic induce agent has bacterium, true Jun and yeast; Abiotic inductor has various organic acids such as Whitfield's ointment, 2,4-D, arachidonic acid etc., rare earth metal salt such as cerous nitrate, Silver Nitrate etc.Up to the present, induce effect best be methyl jasmonate (MJA).((1)Y.Yukimune,H.Tabata,et?al.,Nat.Biotechnol.,14(1996),110-118(2)R.E.B.Ketchum,D.M.Gibson,R.B.Croteau,M.L.Shuler,,Biotechnol.Bioeng.62,97-105,1999)。Methyl jasmonate is an isolated compound odorous from Largeflower Jasmine Flower (Jasminium Gradiflrum) volatile oil at first, also is the important component of jasminine peat-reek.It has very important physiological function, and it has the effect of plant-growth regulator, be the very popular class aromatic compounds of Recent study (guest Jinhua, BULLETIN OF BOTANY Vol., 1995,12 (4), 17-21).It still is the very important plant signal transduction molecule of a class, can excite the disease resistance response (the SAR-system obtains resistance) of plant.Making cell produce anaphylaxis in cell cultures, cause the pathways metabolism of cell and metabolic flux to change, is the inductor of excellent property.People also once made some changes to the natural structure of MJA, attempted to find the better MJA derivative of performance, but existing MJA derivative after modified induce all undesirable (the Otto Miersch of performance, Robert Kramell, et al., Phytochem., 50 (1999), 353-61).
The present invention chooses Chinese Ramulus et folium taxi cuspidatae (T.chinensis) cell as application system, based on the MJA structure, and, hydroxyl fluorine-containing and some plant-growth regulator precursors, design, synthetic a series of vegetable cell inductors by introducing.Experimental result shows: several compounds wherein are better than methyl jasmonate (MJA) in effect aspect the biosynthesizing that promotes Taxan, have suitable practical value.
Jasmonic acid ester compound involved in the present invention has following structural formula:
In the formula: R is OCH
2CF
3, OCH
2CF
2CF
3, OCH
2C
6F
5Or O (CH
2CH
2O)
nR
1
Preferred R is OCH
2CF
3, OCH
2CF
2CF
3, OCH
2C
6F
5Or O (CH
2CH
2O)
nR
1,
R wherein
1Be 2-hydroxy benzoyl or phendioxin, 2,3-thiadiazoles-7-formyl radical, n=1,2, or 3.The synthetic route of above-claimed cpd:
With the methyl jasmonate is raw material, forms jasmonic acid through hydrolysis, with solid phosgene ((Cl
3CO)
2CO) reaction makes the jasmonic acid acyl chlorides, obtains the purpose product with corresponding pure esterification again.
Specific implementation method
The present invention is further illustrated below by embodiment, and the cited case does not limit protection scope of the present invention:
Embodiment one
Synthesizing of jasmonic acid trifluoro ethyl ester (compound 1):
Jasmonic acid (JA) 1.7mmol is dissolved in 20ml exsiccant CH under stirring
2Cl
2In, add 0.56mmol solid phosgene ((Cl
3CO)
2CO) and 3D DMF, add drying tube, argon shield refluxed 18 hours down slightly, be added drop-wise to after the cooling in the solution of forming by 2ml trifluoroethanol and 0.5ml triethylamine, and about 1 hour of dropping time, and then stirred 3 hours.Reaction mixture is poured in the separating funnel, uses the distilled water wash three times of twice at every turn, obtains light brown CH
2Cl
2Solution, anhydrous MgSO
4Dried overnight obtains the sticking shape liquid of brown after the filtering and concentrating.Column chromatography for separation twice obtains weak yellow liquid 0.11 gram, yield 22.6%.
1H?NMR(SF:500MHz,DMSO-d
6),δ(ppm),5.36-5.41(q,1H,J
1=7.34Hz,J
2=10.74Hz,J
3=7.33Hz),5.19-5.13(q,1H,J
1=7.64Hz,J
2=10.56Hz,J
3=7.70Hz),4.72-4.78(q,2H,J
1=9.10Hz,J
2=9.11Hz,J
3=9.11Hz),2.78-2.81(q,1H,J
1=4.23Hz,J
2=11.56Hz,J
3=4.24Hz),2.43-2.46(t,1H,J
1=6.16Hz,J
2=9.64Hz),2.24-2.26(m,4H),1.97-2.10(m,5H),1.42-1.52(m,1H),0.87-0.90(t,3H,J
1=7.48Hz,J
2=7.51)。HRMS,m/e(mass/calc.mass,%):M
+(292.1273/292.1286,75.07);C
12H
12O
2F
+(245.0770/245.0789,11.67),M
+-C
4H
9/C
10H
10O
3F
3 +(235.0566/235.0582,13.84);C
9H
11O
3F
3 +(224.0670/224.0649,56.50);C
12H
17O
2 +(193.1229/193.1229,13.27);C
10H
15O
+(151.1134/151.1123,76.57);C
3H
8O
2F
+(95.0554/95.0508,25.86);C
5H
7O
+(83.0513/83.0497,100.00)。
Embodiment two
Synthesizing of jasmonic acid five fluorine propyl ester (compound 2):
Jasmonic acid (JA) acyl chlorides (preparation method is with embodiment one) dichloromethane solution is added drop-wise in the solution of being made up of 1ml five fluorine propyl alcohol and 0.6ml triethylamine, about 1.5 hours of dropping time, and then stirring at room 12 hours.Reaction mixture is poured in the separating funnel, uses the distilled water wash three times of twice at every turn, obtains light brown CH
2Cl
2Solution, anhydrous MgSO
4Dried overnight obtains the sticking shape liquid of brown after the filtering and concentrating.Column chromatography for separation obtains weak yellow liquid 0.14 gram, yield 24%.
1H?NMR(SF:500MHz,DMSO-d
6),δ(ppm),5.36-5.41(q,1H,J
1=7.31Hz,J
2=10.65Hz,J
3=7.31Hz),5.17-5.22(q,1H,J
1=7.51Hz,J
2=10.77Hz,J
3=7.60Hz),4.80-4.86(t,2H,J
1=13.90Hz,J
2=13.88Hz),2.78-2.82(q,1H,J
1=4.21Hz,J
2=11.64Hz,J
3=4.21Hz),2.43-2.46(t,1H,J
1=6.21Hz,J
2=9.65Hz),2.17-2.27(m,4H),1.96-2.09(m,5H),1.42-1.49(m,1H),0.87-0.90(t,3H,J
1=7.43Hz,J
2=7.51)。HRMS,m/e(mass/calc.mass,%):M
+(342.1218/342.1254,51.53);M
+-H
2O(324.1124/324.1149,4.37);M
+-C
2H
5(13.0852/313.0863,7.36);M
+-C
5H
8(274.0611/274.0628,32.26);C
12H
17O
2 +(193.1212/193.1229,21.12),C
10H
15O
+(151.1109/151.1134,64.67);C
7H
9O
+(109.0698/109.0653,16.44);C
5H
7O
+(83.0497/83.0497,100.00)。
Embodiment three
Synthesizing of jasmonic acid five fluoro-methylbenzyl esters (compound 3)
Except that substituting the trifluoroethanol with five fluoro-methylbenzyl esters, other condition obtains colourless liquid 0.19 gram, productive rate 29% with embodiment one.
1H?NMR(SF:500MHz,DMSO-d
6),δ(ppm),5.32-5.37(q,1H,J
1=7.30Hz,J
2=10.85Hz,J
3=7.27Hz),5.21(s,2H),5.14-5.19(q,1H,J
1=7.62Hz,J
2=10.76Hz,J
3=7.53Hz),2.65-2.69(q,1H,J
1=4.52Hz,J
2=11.04Hz,J
3=4.59Hz),2.34-2.39(q,1H,J
1=9.19Hz,J
2=6.44Hz,J
3=9.25Hz),2.14-2.21(m,4H),1.90-2.06(m,5H),1.41-1.45(t,1H,J
1=9.15Hz,J
2=10.20Hz),0.84-0.87(t,3H,J
1=7.40Hz,J
2=7.50)。HRMS,m/e(mass/calc.mass,%):M
+(390.1250/390.1254,44.46);M
+-H
2O(372.1149/372.1149,4.93);M
+-C
5H
8(322.0607/322.0617,15.08);C
12H
17O
3 +(209.1187/209.1178,12.26),C
7H
2F
5 +(181.0041/181.0077,100.00);C
10H
15O
+(151.1112/151.1123,24.95);C
7H
9O
3 +(141.0550/141.0552,45.91);C
10H
11 +(131.0891/131.0861,10.34);C
6H
7O
+(95.0519/95.0497,13.91);C
5H
7O
+(83.0498/83.0497,15.74)。
Embodiment four
Synthesizing of jasmonic acid sulfo-methyl esters (compound 4):
Jasmonic acid (JA) acyl chlorides (preparation method is with embodiment one) dichloromethane solution is added drop-wise in the 3ml 15% sodium methyl mercaptide solution, about 0.5 hour of dropping time, and then stirring at room 5 hours.Reaction mixture is poured in the separating funnel, uses the distilled water wash three times of twice, anhydrous MgSO at every turn
4Dried overnight obtains brown slime body after the filtering and concentrating.Column chromatography for separation obtains colourless liquid 0.14 gram, productive rate 34.3%.
1H?NMR(SF:500MHz,DMSO-d
6),δ(ppm),5.36-5.41(q,1H,J
1=7.31Hz,J
2=10.78Hz,J
3=7.32Hz),5.16-5.21(q,1H,J
1=7.50Hz,J
2=10.77Hz,J
3=7.50Hz),2.89-2.93(q,1H,J
1=4.47Hz,J
2=10.45Hz,J
3=4.51Hz),2.60-2.65(t,1H,J
1=9.28Hz,J
2=5.73Hz,J
3=9.28Hz),2.16-2.25(m,7H),1.92-2.09(m,5H),1.42-1.51(m,1H),0.88-0.91(t,3H,J
1=7.48Hz,J
2=7.59)。HRMS,m/e(mass/calc.mass,%):M
+(240.1153/240.1184,64.56);M
+-H
2O(222.1093/222.1078,12.28);C
8H
12O
2S
+(172.0550/172.0558,46.32),C
11H
17O
+(165.1409/165.1279,56.38);C
10H
15O
+(151.1100/151.1123,100.00);C
11H
11O
+(135.0813/135.0810,70.24);C
7H
9O
+(109.0726/109.0653,46.27);C
6H
7O
+(95.0586/95.0497,48.46);C
5H
8 +(68.0600/68.0626,10.13)。
Embodiment five
Synthesizing of jasmonic acid (JA) ethylene glycol ester (compound 5):
Jasmonic acid 5mmol and 15ml ethylene glycol mix, and argon gas is saturated down, adds vitriol oil 0.4ml, and heating in water bath is to 50-60 ℃, and in 7 hours reaction times, during cooling was fallen back, ethyl acetate 30ml * 3 extracted, NaHCO
3Solution is washed, and washes anhydrous MgSO 3-4 time
4Dried overnight obtains colourless oil liquid 1.1 grams, yield 85.0% after the filtering and concentrating.
1H?NMR(SF:500MHz,DMSO-d
6),δ(ppm):5.35-5.40(q,1H,J
1=7.31Hz,J
2=10.67Hz,J
3=7.29Hz),5.19-5.24(q,1H,J
1=7.57Hz,J
2=10.59Hz,J
3=7.63Hz),4.4.02-4.04(t,2H,J
1=5.04Hz,J
2=5.09Hz),3.54-3.56(t,2H,J
1=5.02Hz,J
2=5.10Hz),2.63-2.67(q,1H,J
1=4.41Hz,J
2=11.04,J
3=4.38Hz),2.30-2.35(q,1H,J
1=9.26Hz,J
2=6.12Hz,J
3=9.30Hz),2.20-2.25(m,4H),1.95-2.20(m,5H),1.39-1.48(m,1H),0.89-0.90(t,3H,J
1=7.54Hz,J
2=7.53Hz)。HRMS,m/e(mass/calc.mass,%):M
+(254.1517/254.1518,87.15);M
+-H
2O/C
14H
20O
3(236.1372/236.1412,15.63),M
+-OC
2H
4OH/C
12H
17O
2(193.1203/193.1229,4.59);C
10H
15O
+(151.1092/151.1123,100.00);C
6H
13O
3 +(133.0934/133.0865,29.36);C
8H
9O
+(121.0654/121.0653,19.11);C
7H
9O
+(109.0667/109.0653,28.28);C
6H
7O
+(95.0491/95.0497,29.20);C
5H
7O
+(83.0481/83.0497,47.39)。
Embodiment six
Synthesizing of jasmonic acid dimerization ethylene glycol ester (compound 6):
Jasmonic acid 1.67mmol and 6ml two polyoxyethylene glycol mix, and argon gas is saturated to add 6 of the vitriol oils down, and heating in water bath is to 60-70 ℃, to going in the 20ml distilled water anhydrous Na
2CO
3Neutralization, ethyl acetate 15ml * 3 extractions, NaHCO
3Solution is washed, and washes anhydrous MgSO 3-4 time
4Dried overnight obtains colourless oil liquid 0.41 gram, yield 82.5% after the filtering and concentrating.
1H?NMR(SF:500MHz,DMSO-d
6),δ(ppm),5.35-5.39(q,1H,J
1=7.32Hz,J
2=10.78Hz,J
3=7.23Hz),5.18-5.23(q,1H,J
1=7.49Hz,J
2=10.75Hz,J
3=7.52Hz),4.13-4.14(t,2H,J
1=4.61Hz,J
2=4.82Hz),3.58-3.60(t,2H,J
1=4.80Hz,J
2=5.58Hz),3.46-3.48(t,2H,J
1=4.80Hz,J
2=4.58Hz),3.40-3.42(t,2H,J
1=4.88Hz,J
2=5.01Hz),2.64-2.68(q,1H,J
1=4.36Hz,J
2=10.98Hz,J
3=4.40Hz),2.31-2.36(q,1H,J
1=9.23Hz,J
2=6.11Hz,J
3=9.25Hz),2.15-2.25(m,4H),1.92-2.08(m,5H),1.42-1.46(m,1H),0.88-0.91(t,3H,J
1=7.54Hz,J
2=7.52Hz)。HRMS,m/e(mass/calc.mass,%):M
+(298.1794/298.1790,31.18);M
+-H
2O/C
16H
24O
4(280.1737/280.1675,4.95),M
+-OC
2H
4OH(237.1520/237.1491,7.73);C
12H
16O
2 +(192.1195/192.1150,21.41);C
10H
15O
+(151.1126/151.1123,100.00);C
6H
12O
4 +(148.0575/148.0736,33.58);C
10H
13 +(133.1073/133.1017,22.15);C
7H
9O
+(109.0710/109.0653,23.51);C
6H
7O
+(95.0532/95.0497,26.58);C
5H
7O
+(83.0502/83.0497,31.07)。
Embodiment seven
Synthesizing of 1-jasmonic acid-2-(2 hydroxybenzoic acid) second diester (compound 7):
Whitfield's ointment 5 grams add 20ml dry benzene and 10ml SOCl
2, oil bath reflux 5 hours.Cooling, underpressure distillation benzene and unreacted SOCl
2, obtain colourless liquid 4.6 grams.
Take by weighing top synthetic Whitfield's ointment acyl chlorides 1.4mmol, add dry toluene 5ml, this drips of solution is added to the frozen water refrigerative jasmonic acid ethylene glycol ester 1.2mmol, and in the solution of toluene 5ml and triethylamine 0.4ml, add half an hour.Remove ice bath, continue to stir 16 hours, TLC controls reaction.Reaction mixture is poured in the water, ethyl acetate 30ml * 2 extractions, washing twice, anhydrous MgSO
4Dried overnight obtains brown liquid after the filtering and concentrating, the preparation plate separates, and obtains pale yellow oily liquid body 0.11 gram, yield 33%.
1H NMR (SF:500MHz, DMSO-d
6), δ (ppm), 10.43 (s, 1H), 7.74-7.76 (d, 1H, J=7.94Hz), 7.51-7.54 (t, 1H, J
1=8.20Hz, J
2=7.28Hz), and 6.97-6.99 (d, 1H, J=8.32Hz), 6.92-6.94 (t, 1H, J
1=7.55Hz, J
2=7.49Hz), and 5.31-5.33 (q, 1H), 5.14-5.16 (q, 1H), and 4.51-4.53 (t, 2H), 4.398-4.40 (t, 2H), and 2.65-2.69 (q, 1H), 2.31-2.36 (q, 1H), and 2.10-2.22 (m, 4H), 1.90-2.04 (m, 5H), 1.39-1.44 (quintet, 1H), and 0.82-0.85 (t, 3H).HRMS,m/e(mass/calc.mass,%):M
+(374.1715/374.1729,12.52);M
+-C
5H
8(306.1079/306.1103,15.35);C
14H
8O
4 +(240.0423/240.0423,12.64);C
9H
9O
3 +(165.0555/165.0552,14.72);C
10H
15O
+(151.1115/151.1123,9.80);C
7H
5O
2 +(121.0281/121.0290,100.00)。
Embodiment eight
Synthesizing of 1-jasmonic acid-2-(phendioxin, 2,3-thiadiazoles-7-formic acid) second diester (compound 8):
By 0.56mmol 7-carboxyl phendioxin, 2, the acyl chlorides of 3-thiadiazoles preparation is dissolved in the 1.5ml exsiccant toluene, at ambient temperature, be added drop-wise to jasmonic acid (JA) ethylene glycol ester 6.2mmol, in the solution that dry toluene 1.5ml and 0.15ml triethylamine are formed, about 30 minutes of dropping time.Continue reaction 20 hours then.Reaction mixture is poured in the frozen water into ethyl acetate 20ml * 2 extractions, washing twice, anhydrous MgSO
4Dried overnight obtains colourless oil liquid after the filtering and concentrating, 300-400 order silica gel column chromatography separates, and obtains a small amount of colourless liquid.
1H NMR (SF:500MHz, DMSO-d
6), δ (ppm) 9.04-9.06 (d, 1H, J=8.33Hz), 8.40-8.41 (d, 1H, J=7.29Hz), 7.93-7.96 (t, 1H, J
1=7.82Hz, J
2=7.80Hz), and 520-5.25 (q, 1H), 5.07-5.12 (q, 1H), and 4.64-4.65 (t, 2H), 4.45-4.46 (t, 2H), and 2.65-2.66 (q, 1H), 2.32-2.37 (q, 1H), and 2.11-2.18 (m, 4H), 1.80-2.03 (m, 4H), and 1.37-1.45 (sextet, 1H), 1.06-1.08 (t, 1H), and 0.75-0.79 (t, 3H).HRMS,m/e(mass/calc.mass,%):M
+(416.1423/416.1406,14.05);M
+-C
5H
8/C
16H
16N
2O
5S(348.0736/348.0780,100.00),M
+-C
10H
14O/C
11H
10N
2O
4S(266.0328/266.0361,90.32);C
9H
9N
2O
3S
+(225.0331/225.0334,41.11);C
9H
7N
2O
2S
+(207.0246/207.0228,19.76);C
7H
5N
2O
2S
+(181.0121/181.0072,29.70);C
7H
3OS
+(134.9928/134.9905,52.71);C
6H
3S
+(106.9988/106.9955,17.70);C
6H
7O
+(95.0524/95.0497,10.75)。
Embodiment nine
1-jasmonic acid-2 '-(2 hydroxybenzoic acid) dimerization ethylene glycol diester (compound 9) synthetic:
Jasmonic acid (JA) acyl chlorides (preparation method is with embodiment one) dichloromethane solution is added drop-wise to by 0.4 gram Whitfield's ointment tirethylene glycol monoesters (1.77mmol), in the solution that 10ml methylene dichloride and 0.5ml triethylamine are formed, added stirring at room reaction 10 hours in 30 minutes.Washing, anhydrous magnesium sulfate drying.Obtain brown slime body after the filtering and concentrating.Column chromatography for separation obtains a small amount of weak yellow liquid.
1H NMR (SF:500MHz, DMSO-d
6), δ (ppm), 10.47 (s, 1H), 7.78-7.79 (d, 1H, J=7.92Hz), 7.51-7.54 (t, 1H, J
1=8.40Hz, J
2=7.11Hz), and 6.92-6.98 (m, 2H), 5.31-5.33 (q, 1H), 5.32-5.40 (q, 1H, J
1=13.41Hz, J
2=14.71Hz, J
3=11.26Hz), 5.15-5.23 (q, 1H, J
1=13.01Hz, J
2=15.17Hz, J
3=10.76Hz), 4.41-4.43 (t, 2H, J
1=4.32Hz, J
2=4.67Hz), 4.15-4.17 (t, 2H, J
1=4.21Hz, J
2=5.11Hz), 3.76-3.78 (t, 2H, J
1=4.70Hz, J
2=4.42Hz), 3.66-3.68 (t, 2H, J
1=4.44Hz, J
2=4.95Hz), and 2.58-2.62 (q, 1H), 2.29-2.58 (m, 1H), 1.86-2.07 (m, 10H), 1.36-1.42 (quintet, 1H), 0.85-0.88 (t, 3H, J
1=7.37Hz, J
2=7.39Hz).HRMS,m/e(mass/calc.mass,%):M
+(418.1798/418.1992,13.83);M
+-C
5H
8(50.1375/350.1366,2.70);C
16H
26O
5 +(298.1876/298.1780,9.10);C
14H
20O
5 +(268.1276/268.1311,2.94);C
11H
15O
5 +(227.0994/227.0919,3.76);C
12H
16O
2 +(192.1241/192.1150,4.86);C
9H
9O
3 +(165.0582/165.0552,11.56);C
7H
5O
2 +(121.0310/121.0290,100.00);C
6H
4O
+(92.0296/92.0262,6.37)。
Jasmonic acid ester compound Application Example (cultivation of taxus chinensis cell, the production of Tc and measuring method referring to the clock Kien Giang, Dong Haodi, Chinese invention patent application number 00125305.0):
Embodiment ten
The taxus chinensis cell that employing obtains from plant children stem explant induction callus.The 250mL shake-flask culture adopts the MS substratum, and other adds the 0.5mg/L 6-benzyladenine, 0.2mg/L 2,4 dichlorophenoxyacetic acid, 0.2mg/L naphthylacetic acid, 100mg/L xitix and 30mg/L sucrose.
The 5g wet cell that vacuum filtration is obtained is inoculated into and contains the shaking in the bottle of the above-mentioned substratum of 50mL, secretly cultivates in rotary shaking speed is 110rpm, 25 ℃.First group in contrast; Second group added at the 7th day MJA to ultimate density be 100 μ M; The 3rd group was added compound 1 to ultimate density at the 7th day is 100 μ M; The 4th group was added compound 5 to ultimate density at the 7th day is 100 μ M; The 5th group was added compound 7 to ultimate density at the 7th day is 100 μ M; The 6th group was added compound 8 to ultimate density at the 7th day is 100 μ M, continues to be cultured to end in the 21st day, and harvested cell also is dried to constant weight at 40 ℃.Each organizes cell density and the Tc analytical results is as shown in the table.
The highest Tc turnout of the highest Tc content of maximum cell density
Condition
(gDW·L
-1) [mg·(gDW)
-1] (mg·L
-1)
First group of (contrast) 15.3 ± 0.2 (day 12), 14.0 ± 0.1 (day 21) 149 ± 4 (day 21)
Second group of (MJA) 15.3 ± 0.1 (day 12), 33.7 ± 1.6 (day 18) 402 ± 22 (day 18)
The 3rd group of (compound 1) 15.1 ± 0.2 (day 12) 39.7 ± 1.1 (day 21) 440 ± 6 (day 18)
The 4th group of (compound 5) 14.6 ± 0.2 (day 12) 44.3 ± 1.1 (day 21) 472 ± 12 (day 15)
The 5th group of (compound 7) 14.8 ± 0.1 (day 12) 40.3 ± 0.6 (day 21) 434 ± 8 (day 12)
The 6th group of (compound 8) 13.9 ± 0.2 (day 12) 39.6 ± 0.8 (day 18) 427 ± 15 (day 18)
Embodiment 11
Culture condition is with example ten.First group in contrast; Second group at the 7th day interpolation compound 2 to 100 μ M; The 3rd group was added compound 6 to 100 μ M at the 7th day, continued to be cultured to end in the 21st day.Each organizes cell density and the Tc analytical results is as shown in the table.
The highest Tc turnout of the highest Tc content of maximum cell density
Condition
(gDW·L
-1) [mg·(gDW)
-1] (mg·L
-1)
First group of (contrast) 16.3 ± 0.1 (day 12), 13.0 ± 0.0 (day 21) 182 ± 16 (day 15)
Second group of (compound 2) 16.3 ± 0.1 (day 12), 38.2 ± 1.7 (day21) 480 ± 25 (day 21)
The 3rd group of (compound 6) 13.1 ± 0.2 (day 21) 34.2 ± 0.1 (day 21) 464 ± 17 (day 15)
Embodiment 12
Culture condition is with example ten.First group in contrast; Second group at the 7th day interpolation compound 4 to 100 μ M; The 3rd group was added compound 9 to 100 μ M at the 7th day, continued to be cultured to end in the 21st day.Each organizes cell density and the Tc analytical results is as shown in the table.
The highest Tc turnout of the highest Tc content of maximum cell density
Condition
(gDW·L
-1) [mg·(gDW)
-1] (mg·L
-1)
First group of (contrast) 15.6 ± 1.0 (day 12), 9.8 ± 0.1 (day 18) 139 ± 1 (day 18)
Second group of (compound 4) 14.6 ± 0.2 (day 15), 30.9 ± 2.5 (day 21) 380 ± 26 (day 18)
The 3rd group of (compound 9) 14.8 ± 1.0 (day 12) 31.4 ± 1.4 (day 21) 381 ± 27 (day 21)
Embodiment 13
Culture condition is with example ten.First group in contrast; The second-five group was added compound 1 to ultimate density at the 7th day respectively is 1,10,100,500 μ M, continues to be cultured to end in the 21st day.Each organizes cell density and the Tc analytical results is as shown in the table.
The highest Tc turnout of the highest Tc content of maximum cell density
Condition
(gDW·L
-1) [mg·(gDW)
-1] (mg·L
-1)
First group of (contrast) 16.1 ± 0.5 (day 12), 11.8 ± 2.2 (day 21) 147 ± 24 (day 21)
Second group (1 μ M) 16.1 ± 0.3 (day 12) 13.1 ± 0.5 (day 21) 167 ± 5 (day 21)
The 3rd group (10 μ M) 16.2 ± 0.2 (day 12) 19.4 ± 3 (day 21) 261 ± 1 (day 21)
The 4th group (100 μ M) 15.6 ± 0.2 (day 12) 34.7 ± 0.3 (day 21) 404 ± 5 (day 21)
The 5th group (500 μ M) 13.2 ± 0.1 (day 12) 43.1 ± 0.3 (day 21) 406 ± 12 (day 21)
Embodiment 14
Culture condition is with example ten.First group at the 7th day interpolation sucrose 20g/L; Second group was added sucrose 20g/L at the 7th day, and added compound 1 to 100 μ M simultaneously, continued to be cultured to end in the 21st day.Each organizes cell density and the Tc analytical results is as shown in the table.
The highest Tc turnout of the highest Tc content of maximum cell density
Condition
(gDW·L
-1) [mg·(gDW)
-1] (mg·L
-1)
First group of 24.6 ± 0.2 (day 18) 9.1 ± 0.9 (day 12) 171 ± 4 (day 21)
Second group of 21.9 ± 0.4 (day 15) 27.3 ± 1.1 (day 12) 564 ± 12 (day 18)
Claims (4)
2, compound as claimed in claim 1 is characterized in that, wherein R is OCH
2CF
3, OCH
2CF
2CF
3Or OCH
2C
6F
5
3, compound as claimed in claim 1 is characterized in that, wherein R is O (CH
2CH
2O)
nR
1, R in the formula
1Be 2-hydroxy benzoyl or phendioxin, 2,3-thiadiazoles-7-formyl radical, n=1,2, or 3.
4, as claim 1~3 application of compound as described in each, described compound is used to promote the growth of vegetable cell secondary metabolite as the vegetable cell inductor.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03129466 CN1193979C (en) | 2003-06-23 | 2003-06-23 | Jasmine keto ester derivatives and their use in plant cell |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03129466 CN1193979C (en) | 2003-06-23 | 2003-06-23 | Jasmine keto ester derivatives and their use in plant cell |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1470494A CN1470494A (en) | 2004-01-28 |
CN1193979C true CN1193979C (en) | 2005-03-23 |
Family
ID=34153546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03129466 Expired - Fee Related CN1193979C (en) | 2003-06-23 | 2003-06-23 | Jasmine keto ester derivatives and their use in plant cell |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1193979C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102986391A (en) * | 2011-09-08 | 2013-03-27 | 郑州大学 | Method for improving content and aromas of tobacco secondary metabolite products |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0619492A2 (en) * | 2005-12-07 | 2011-10-04 | Univ Ramot | jasmonate chemical derivatives, pharmaceutical compositions and methods of use |
US9284274B2 (en) | 2005-12-07 | 2016-03-15 | Ramot At Tel-Aviv University Ltd. | Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
WO2008151526A1 (en) * | 2007-06-08 | 2008-12-18 | Dalian Institute Of Chemical Physics, Chinese Academy Of Sciences | A method of inducing taxane production |
US9284252B2 (en) | 2009-06-09 | 2016-03-15 | Sepal Pharma Ltd. | Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders |
-
2003
- 2003-06-23 CN CN 03129466 patent/CN1193979C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102986391A (en) * | 2011-09-08 | 2013-03-27 | 郑州大学 | Method for improving content and aromas of tobacco secondary metabolite products |
Also Published As
Publication number | Publication date |
---|---|
CN1470494A (en) | 2004-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mori et al. | Stereocontrolled synthesis of all of the four possible stereoisomers of erythro-3, 7-dimethyl-pentadec-2-yl acetate and propionate, the sex pheromone of the pine sawflies | |
DE69618812T2 (en) | INTERMEDIATE PRODUCTS FOR THE HEMISYNTHESIS OF TAXANS AND THEIR METHOD FOR THE PRODUCTION THEREOF | |
CN101223121B (en) | Preparation of glycerol derivatives and intermediates therefor | |
CN100593024C (en) | Process of synthesizing taxol and docetaxel | |
CN1193979C (en) | Jasmine keto ester derivatives and their use in plant cell | |
CN110407847B (en) | Azaphilones compounds obtained from aspergillus terreus and preparation and application thereof | |
EP2091932B1 (en) | Semi-synthesis and isolation of taxane intermediates from a mixture of taxanes | |
CN1266058A (en) | Process for refining lipstatin | |
JP2014534183A (en) | Method for isolating ingenol | |
Chinthanom et al. | Lanostane triterpenoids from cultivated fruiting bodies of Ganoderma sichuanense: Determination of the C-25 absolute configuration of ganoderic acid A and its derivatives using the phenylglycine methyl ester (PGME) method | |
CN1202097C (en) | Diazosulfide compound and application in plant cell thereof | |
CN1234696C (en) | Taxad alkyl derivative and its prepn. process | |
Kalashnikov et al. | Facile method for the synthesis of oseltamivir phosphate | |
Matsui et al. | Synthesis and structure of orobanchol, the germination stimulant for Orobanche minor | |
Shepherd et al. | Synthesis of the cyclopentane core of pepluanin A | |
CN101033216A (en) | Oxazolidine compound for synthesizing taxone pharmaceutical side-chain and preparation method thereof | |
US20150329463A1 (en) | Process for the preparation of ingenol-3-angelate from 20-deoxy-ingenol | |
CN86107090A (en) | The preparation method of Clausenamide | |
CN1273481C (en) | 17 alpha, 22-dicarboxy furo compound and its use | |
Ganbaatar et al. | Coumarins from Peucedanum hystrix growing in Mongolia | |
CN1844138A (en) | Process for synthesizing OSW-1 by removing protective group | |
CN110105368B (en) | Deoxy taxane analogs and preparation method thereof | |
Reddy et al. | Stereoselective Total Synthesis of the Natural Oxylipin (6R, 7E, 9R, 10S)-6, 9, 10-Trihydroxyoctadec-7-enoic Acid1 | |
Morikawa et al. | Stereoselective radical additions of γ-oxy-α, β-unsaturated ester derivatives; 1, 2-asymmetric induction in acyclic and cyclisation systems | |
CN1298730C (en) | Steroid framework compound, synthesizing process and its use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050323 Termination date: 20140623 |
|
EXPY | Termination of patent right or utility model |